




Preparing video
The S&P/ASX 200 struggled to hold onto its intraday gains but finished on an 0.57% upside this Wednesday, to 8,653.30 points. Investors weighed weaker Wall Street signals and conflicting updates from the Middle East.
Defensive names found support, with investors buying into Woolworths and Coles, while CSL was also a bright spot in healthcare. Meanwhile, Sigma Healthcare fell 5.3% with investors seemingly concerned by its potential $14B bid for iconic UK pharmacy Boots.
The consumer staples sector was broadly firmer, with Wesfarmers up 3.8% after its strategy day update included a lithium project extension, and potential new property projects for Bunnings.
The mining sector struggled to keep pace, with gold stocks again firmly in the red. Newmont shed 3.3% over the session.
In tech, Megaport announced a partnership with VAST Data to provide the data platform for its global network and compute infrastructure.
And defence technology company Boresight rocketed 67.5% on its ASX debut, while Steadfast jumped 35% on a takeover bid.
Tonight; the key focus is US CPI, the first monthly read under Fed Chair Kevin Warsh, which will help shape expectations for the Fed’s next move.